Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti, F
Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation. [electronic resource] - Journal of hepatology Jan 1997 - 167-73 p. digital
Publication Type: Journal Article
0168-8278
10.1016/s0168-8278(97)80023-2 doi
Animals
Antihypertensive Agents--therapeutic use
Cholestasis--complications
Drug Evaluation, Preclinical
Drug Therapy, Combination
Hemodynamics--drug effects
Hypertension, Portal--etiology
Liver Cirrhosis, Experimental--complications
Male
Multivariate Analysis
Propranolol--therapeutic use
Rats
Rats, Sprague-Dawley
Spironolactone--therapeutic use
Splanchnic Circulation--drug effects
Time Factors
Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation. [electronic resource] - Journal of hepatology Jan 1997 - 167-73 p. digital
Publication Type: Journal Article
0168-8278
10.1016/s0168-8278(97)80023-2 doi
Animals
Antihypertensive Agents--therapeutic use
Cholestasis--complications
Drug Evaluation, Preclinical
Drug Therapy, Combination
Hemodynamics--drug effects
Hypertension, Portal--etiology
Liver Cirrhosis, Experimental--complications
Male
Multivariate Analysis
Propranolol--therapeutic use
Rats
Rats, Sprague-Dawley
Spironolactone--therapeutic use
Splanchnic Circulation--drug effects
Time Factors